Resources

Share this article

The prevalence and treatment of oedema at the end of life: a retrospective review of 400 cases

Amanda Landers, Angela Huor
25 February 2021

Oedema at the end of life (OATEOL) is common and causes functional disability and psychological distress. The purpose of this study was to estimate the prevalence of OATEOL in a palliative care population and document the treatment options being offered. A retrospective case note review of 400 patients was conducted by the authors. Of the patients reviewed, 114 (28.5%) had a diagnosis of OATEOL. Most patients had a primary diagnosis of malignancy (78%) and approximately a quarter had non-cancer illnesses (22%). OATEOL was categorised as either lymphatic, non-lymphatic or mixed oedema. The majority of participants with OATEOL were categorised as non-lymphatic. Across all oedema subtypes, the range of treatments offered were inadequate and inconsistent according to best practice.

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.